Crossmark

Persistence and adherence to sodium-glucose co-transporter 2 inhibitor monotherapy among patients with type 2 diabetes mellitus: a retrospective study based on a Japanese claims database

Crossref DOI link: https://doi.org/10.1007/s13340-025-00821-1

Published Online: 2025-05-29

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mukai, Junichi https://orcid.org/0000-0003-0441-8968
Akazawa, Manabu

Yoshiyama, Yuji

Kubota, Rie
License Information

Text and Data Mining valid from 2025-05-29

Version of Record valid from 2025-05-29
More Information

Article History

Received: 16 July 2024

Accepted: 7 May 2025

First Online: 29 May 2025

Declarations

:

: MA received lecture fees from Takeda Pharmaceutical Company Limited and consulting fees from Shionogi & Co., Ltd., Astellas Pharma, Inc, GSK plc, and Janssen Pharmaceutical K.K. The other authors declare no competing interests.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

Document is current

Any future updates will be listed below